The cochlear implants market valued at US$ 2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ ...
BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system.
The cochlear implants market valued at US$ 2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 2.80 Billion in 2024 and an impressive US$ 4.73 Billion by 2030. The ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果